Related Experiment Videos

Na_V1.7 as a pain target - From gene to pharmacology

Irina Vetter¹, Jennifer R Deuis², Alexander Mueller²

¹Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, St Lucia, Qld 4072, Australia; School of Pharmacy, The University of Queensland, Woolloongabba, Qld 4102, Australia.

Pharmacology & Therapeutics

|December 6, 2016

Abstract

No abstract available in PubMed .

Keywords:

Congenital insensitivity to pain Inherited erythromelalgia Pain Paroxysmal extreme pain disorder Sensory neuron Sodium channel

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Antigen-Detected NMR for Minimal Epitope Engineering and Structure-Guided Selection of a NaV1.7-Selective Nanobody.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Mimics of the chordate gut-brain hormone neurotensin in parasitic intestinal hookworms.

Current biology : CB·2026

Electrostatic tuning of NaV channel activation by the domain II S3-S4 extracellular loop.

The Journal of physiology·2026

Why pharmacogenomic biomarkers for chemotherapy-induced peripheral neuropathy fail: a systematic review of genetic associations, replication, and clinical translation.

Frontiers in pharmacology·2026

The Cluster Completeness Correction Calculator (c-4): a neural-network framework and pilot application to the LEGUS survey of NGC 628.

Monthly notices of the Royal Astronomical Society·2026

Distinct neuroinflammatory effects of individual chemotherapeutics shape chemotherapy-induced peripheral neuropathy in a novel mouse model of CVAD combination regimen.

Pain·2026

See all related articles